Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase‐plasminogen activator and matrix metalloproteinase‐2

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Carcinogenesis

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.20018PMID 15224346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders

  2012cited by this paper
• The Use of Silymarin in the Treatment of Liver Diseases

  2012cited by this paper
• Integrin Signaling

  2005cited by this paper
• Matrix Metalloproteinases and Cellular Fibrinolytic Activity

  2004influential reference
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Structure , Function , and Biochemistry

  2003cited by this paper
• Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.

  2003cited by this paper
• Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice.

  2003cited by this paper
• Silibinin inhibits constitutive and TNFα-induced activation of NF-κB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis

  2002cited by this paper
• The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer.

  2002cited by this paper
• Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.

  2002cited by this paper
• Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.

  2002cited by this paper
• Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.

  2002cited by this paper
• Flavonoid Antioxidant Silymarin and Skin Cancer

  2002cited by this paper
• Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• Matrix metalloproteinases in tumor invasion: Role for cell migration

  2002cited by this paper
• Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2*

  2002cited by this paper
• Differential Responses of Skin Cancer-Chemopreventive Agents Silibinin, Quercetin, and Epigallocatechin 3-Gallate on Mitogenic Signaling and Cell Cycle Regulators in Human Epidermoid Carcinoma A431 Cells

  2001cited by this paper
• Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells*

  2001cited by this paper
• Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells.

  2000cited by this paper
• Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.

  2000cited by this paper
• Matrix metalloproteinases in wound repair (review).

  2000cited by this paper
• Integrin signaling.

  1999cited by this paper
• Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin.

  1999cited by this paper
• Regulation of matrix metalloproteinase expression in tumor invasion

  1999cited by this paper
• Matrix metalloproteinases and metastasis

  1999cited by this paper
• Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.

  1998cited by this paper
• Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines.

  1998cited by this paper
• Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

  1998cited by this paper
• Activation mechanisms of matrix metalloproteinases.

  1997influential reference
• Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.

  1997cited by this paper
• Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.

  1996cited by this paper
• Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.

  1996cited by this paper
• Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

  1995cited by this paper
• Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells.

  1992cited by this paper
• Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

  1990cited by this paper
• Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

  1988cited by this paper
• A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells.

  1986cited by this paper
• Biochemical interactions of tumor cells with the basement membrane.

  1986cited by this paper
• Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein.

  1983cited by this paper

• Deciphering the cancer chemopreventive potential of phytochemicals: an integrative perspective on molecular targets and signaling networks.

  2026cites this paper
• Lipids: Driving Forces in the Underlying Biology of Carcinogenesis.

  2025cites this paper
• Milk Thistle (Silybum marianum): Potential Role in Cancer Prevention.

  2025cites this paper
• Silybin-Functionalized PCL Electrospun Fibrous Membranes for Potential Pharmaceutical and Biomedical Applications

  2024cites this paper
• Hepatoprotective Effects of Silybum Marianum Extraction Against Acetamiprid-Induced Stress Oxidative in Male Rats: Potential Anticancer Application

  2024cites this paper
• Silymarin in combination with ATRA enhances apoptosis induction in human acute promyelocytic NB4 cells.

  2023cites this paper
• Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations

  2023cites this paper
• Contrary to known silibinin is not an anticancer agent and liver protective supplement

  2023cites this paper
• The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.

  2023cites this paper
• Pharmacological screening of silibinin for antischizophrenic activity along with its acute toxicity evaluation in experimental animals

  2023cites this paper
• Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions

  2022cites this paper
• Novel molecules as the emerging trends in cancer treatment: an update

  2022cites this paper
• Natural Compounds Targeting Major Signaling Pathways in Lung Cancer

  2021cites this paper
• Lung Cancer Management with Silibinin: A Historical and Translational Perspective

  2021cites this paper
• How cancer cells remodel lipid metabolism: strategies targeting transcription factors

  2021cites this paper
• SİLİMARİN, SLIT2 PROTEİNİNİ AKTİVE EDEREK VE CXCR4 EKSPRESYONUNU BASKILAYARAK A549 HÜCRELERİNİ İNHİBE ETTİ

  2021cites this paper
• Insights of Nanophytomedicines as a Combinatorial Therapy in Disease Diagnosis and Treatment

  2020cites this paper
• Anti-cancer Effects of Silibinin: The Current Status in Cancer Chemoprevention

  2020cites this paper
• Overview of Silibinin anti-tumor effects

  2020cites this paper
• Antimetastatic effects of VOflavonoid complexes on A549 cell line.

  2020cites this paper
• Phytochemicals and cancer chemoprevention

  2020cites this paper
• Phytochemicals and Their Role in Pharmaceuticals

  2020cites this paper
• Advances in Pharmaceutical Biotechnology: Recent Progress and Future Applications

  2020cites this paper
• Nanophytomedicine: Concept to Clinic

  2020cites this paper
• Silibinin releasing mesoporous bioactive glass nanoparticles with potential for breast cancer therapy

  2020cites this paper
• Inhibitory effect of a gamma-oryzanol-rich fraction from purple rice extract on lipopolysaccharide-induced metastasis in human colon cancer cells.

  2020cites this paper
• Silibinin A decreases statin‑induced PCSK9 expression in human hepatoblastoma HepG2 cells.

  2019cites this paper
• Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers

  2019cites this paper
• Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species‐induced apoptosis and reduces cell stemness

  2019cites this paper
• Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling

  2019cites this paper
• Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells

  2019cites this paper
• Nutraceuticals for the Prevention and Cure of Cancer

  2019cites this paper
• Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells

  2019cites this paper
• Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway

  2018cites this paper
• Silymarin and Oral Health

  2018cites this paper
• Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines

  2018cites this paper
• Silymarin as Herbal Medicine- A Review

  2018cites this paper
• Silibinin Improves TNF-α and M30 Expression and Histological Parameters in Rat Kidneys After Hepatic Ischemia/Reperfusion

  2018cites this paper
• Anticancer Attributes of Silibinin: Chemo- and Radiosensitization of Cancer

  2018cites this paper
• Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein‐9 and MAPK pathway

  2018cites this paper
• Anthocyanins from Hibiscus sabdariffa calyx attenuate in vitro and in vivo melanoma cancer metastasis

  2018cites this paper
• Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways

  2017cites this paper
• Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems

  2017cites this paper
• Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression.

  2017cites this paper
• Silibinin Cytotoxic Effect on MCF-7 Cell Line

  2017cites this paper
• Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial–mesenchymal transition

  2017cites this paper
• Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells

  2017cites this paper
• Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer

  2017cites this paper
• Effect of Silibinin on Maspin and ERα Gene Expression in MCF-7 Human Breast Cancer Cell Line

  2017cites this paper
• Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.

  2017cites this paper
• Silibinin in cancer therapy : A promising prospect

  2016cites this paper
• MMP2-Targeting and Redox-Responsive PEGylated Chlorin e6 Nanoparticles for Cancer Near-Infrared Imaging and Photodynamic Therapy.

  2016cites this paper
• Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways

  2016cites this paper
• Protective effect of silymarin against chemical-induced cardiotoxicity

  2016cites this paper
• Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo

  2016cites this paper
• In Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells

  2016cites this paper
• Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway

  2016cites this paper
• بررسی اثر سایتوتوکسیک سیلیبینین بر رده سلولی MCF-7

  2016cites this paper
• Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

  2016cites this paper
• Herbal product silibinin-induced programmed cell death is enhanced by metformin in cervical cancer cells at the dose without influence on nonmalignant cells

  2015cites this paper
• Imatinib induces down-regulation of Bcl-2 an anti-apoptotic protein in prostate cancer PC-3 cell line

  2015cites this paper
• Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

  2015cites this paper
• Trolox induces inhibition of cell proliferation and apoptosis in human colon cancer cells

  2015cites this paper
• Supercritical CO₂ extraction of oil, fatty acids and flavonolignans from milk thistle seeds: Evaluation of their antioxidant and cytotoxic activities in Caco-2 cells.

  2015cites this paper
• Cochinchina momordica seed suppresses proliferation and metastasis in human lung cancer cells by regulating multiple molecular targets.

  2015cites this paper
• Evaluation of putative cytotoxic activity of crude extracts from Onopordum acanthium leaves and Spartium junceum flowers against the U-373 glioblastoma cell line.

  2015cites this paper
• Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells.

  2015cites this paper
• The Role of Sodium-Dependent Glucose Transporter 1 and Glucose Transporter 2 in the Absorption of Cyanidin-3-O-β-Glucoside in Caco-2 Cells

  2014cites this paper
• Inhibition of the invasion and migration of renal carcinoma 786‑o‑si3 cells in vitro and in vivo by Koelreuteria formosana extract.

  2014cites this paper
• In vitro anticancer effects of insect tea in TCA8113 cells.

  2014cites this paper
• Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway

  2014cites this paper
• Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.

  2014cites this paper
• Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.

  2014cites this paper
• Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment.

  2014cites this paper
• Effect of Silibinin on the Induction of Apoptosis and the Inhibition of Cell Growth on the MCF-7 Cell Line

  2014cites this paper
• Dietary Polyphenols for Prostate Cancer Therapy

  2014cites this paper
• Chemopreventive and Anti-Cancer Efficacy of Silibinin Against Growth and Progression of Lung Cancer

  2013cites this paper
• Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.

  2013cites this paper
• Selaginella tamariscina extract suppresses TPA-induced invasion and metastasis through inhibition of MMP-9 in human nasopharyngeal carcinoma HONE-1 cells

  2013cites this paper
• Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

  2013cites this paper
• Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?

  2013cites this paper
• Mulberry 1-deoxynojirimycin pleiotropically inhibits glucose-stimulated vascular smooth muscle cell migration by activation of AMPK/RhoB and down-regulation of FAK.

  2013cites this paper
• Inhibitory effects of dried longan (Euphoria longana Lam.) seed extract on invasion and matrix metalloproteinases of colon cancer cells.

  2013cites this paper
• Effects of dried longan seed (Euphoria longana Lam.) extract on VEGF secretion and expression in colon cancer cells and angiogenesis in human umbilical vein endothelial cells

  2013cites this paper
• Dual Effects of Silymarin on Nasopharyngeal Carcinoma Cells (NPC-TW01)

  2013cites this paper
• Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer

  2013cites this paper
• Assessment of the anti-invasion potential and mechanism of select cinnamic acid derivatives on human lung adenocarcinoma cells.

  2013cites this paper
• Review on Functions of Dietary Agents and Plants in Cancer Prevention and Treatment

  2013cites this paper
• Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid.

  2013cites this paper
• Sulforaphane inhibits smooth muscle cell proliferation and migration by reducing MMP-9 activity via the Ras and RhoA/ROCK pathways

  2013cites this paper
• Antitumor and antioxidant status of Terminalia catappa against Ehrlich ascites carcinoma in Swiss albino mice

  2013cites this paper
• Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.

  2013cites this paper
• Antimetastatic Potentials of Phyllanthus urinaria L on A549 and Lewis Lung Carcinoma Cells via Repression of Matrix-Degrading Proteases

  2012cites this paper
• Cellular and molecular targets of silibinin, a natural flavonoid, in colorectal cancer prevention and therapy

  2012cites this paper
• Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes

  2012cites this paper
• Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.

  2012cites this paper
• Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity

  2012cites this paper
• Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog

  2012cites this paper
• Suppression of 12-O-Tetradecanoylphorbol-13-Acetate-Induced MCF-7 Breast Adenocarcinoma Cells Invasion/Migration by α-Tomatine Through Activating PKCα/ERK/NF-κB-Dependent MMP-2/MMP-9 Expressions

  2012cites this paper
• Power from the garden: plant compounds as inhibitors of the hallmarks of cancer.

  2012cites this paper